Financial reports
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
10-Q
2021 Q2
Quarterly report
4 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
Current reports
8-K
AlerisLife Announces Closing of Tender Offer
20 Mar 23
8-K
ABP Acquisition to Acquire AlerisLife for $1.31 Per Share
3 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 Nov 22
8-K
AlerisLife Inc. Announces Third Quarter 2022 Results
2 Nov 22
8-K
Departure of Directors or Certain Officers
17 Oct 22
8-K
Departure of Directors or Certain Officers
19 Sep 22
8-K
AlerisLife Inc. Announces Second Quarter 2022 Results
3 Aug 22
8-K
Departure of Directors or Certain Officers
8 Jun 22
8-K
AlerisLife Inc. Announces First Quarter 2022 Results
3 May 22
8-K
AlerisLife Inc. Announces Fourth Quarter and Year End 2021 Results
24 Feb 22
Registration and prospectus
15-12G
Securities registration termination
30 Mar 23
25-NSE
Exchange delisting
20 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Mar 23
Proxies
DEFA14A
Additional proxy soliciting materials
6 Apr 22
DEF 14A
Definitive proxy
6 Apr 22
DEFA14A
Additional proxy soliciting materials
7 Apr 21
DEF 14A
Definitive proxy
7 Apr 21
DEFA14A
Additional proxy soliciting materials
12 May 20
DEFA14A
Additional proxy soliciting materials
15 Apr 20
DEF 14A
Definitive proxy
15 Apr 20
DEFA14A
Additional proxy soliciting materials
9 May 19
DEFA14A
Additional proxy soliciting materials
25 Apr 19
DEFA14A
Additional proxy soliciting materials
25 Apr 19
Other
EFFECT
Notice of effectiveness
27 Mar 23
EFFECT
Notice of effectiveness
27 Mar 23
EFFECT
Notice of effectiveness
27 Mar 23
EFFECT
Notice of effectiveness
27 Mar 23
EFFECT
Notice of effectiveness
27 Mar 23
CT ORDER
Confidential treatment order
15 Mar 23
UPLOAD
Letter from SEC
9 Mar 23
CORRESP
Correspondence with SEC
8 Mar 23
UPLOAD
Letter from SEC
3 Mar 23
UPLOAD
Letter from SEC
3 Mar 23
Ownership
SC 13D/A
DIVERSIFIED HEALTHCARE TRUST
23 Mar 23
4
ADAM D. PORTNOY
20 Mar 23
SC 13D/A
ABP Acquisition LLC
20 Mar 23
4
Heather Pereira
20 Mar 23
4
GERARD M. MARTIN
20 Mar 23
4
DONNA D. FRAICHE
20 Mar 23
4
BRUCE M. GANS
20 Mar 23
4
BARBARA D. GILMORE
20 Mar 23
4
Philip Benjamson
20 Mar 23
4
Stephen R. Geiger
20 Mar 23